In the BioHarmony Drug Report Database
Procarbazine
Matulane (procarbazine) is a small molecule pharmaceutical. Procarbazine was first approved as Matulane on 1982-01-01. It is used to treat brain neoplasms, hodgkin disease, lung neoplasms, melanoma, and multiple myeloma amongst others in the USA.
Trade Name
|
Matulane |
|---|---|
Common Name
|
procarbazine |
ChEMBL ID
|
CHEMBL1321 |
Indication
|
brain neoplasms, hodgkin disease, lung neoplasms, melanoma, multiple myeloma, non-hodgkin lymphoma |
Drug Class
|
Image (chem structure or protein)